Biotech IPOs like iSpecimen soar on COVID fears, but in-person servicers like AirSculpt sink
400tmax/iStock via Getty Images
- Friday’s COVID-related market selloff had a mixed impact on shares of recent IPOs – with lockdown-sensitive names like fat-removal firm AirSculpt Technologies (NASDAQ:AIRS) sinking, but biotechs like iSpecimen (NASDAQ:ISPC)…
